Study of Ipatasertib (GDC-0068)

Study of Ipatasertib (GDC-0068)

Type/Disease Site:
Breast
Trial Category:
Breast
Phase
III
Location(s)
Nebraska Cancer Specialists
Omaha
Nebraska
Contact(s)
Faye Park
Phone
402-691-6972

A Phase II Randomized, Double-blind, Study of Ipatasertib (GDC-0068), An AKT inhibitor, In combination with  Paclitaxel as neoadjuvant treatment for patients with early stage triple negative breast cancer

 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members